These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36296562)

  • 1. Not Just Anticoagulation-New and Old Applications of Heparin.
    Zang L; Zhu H; Wang K; Liu Y; Yu F; Zhao W
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress on Antiviral Activity of Heparin.
    Wang Y; Zhang Y; Wang P; Jing T; Hu Y; Chen X
    Curr Med Chem; 2024; 31(1):7-24. PubMed ID: 36740803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.
    Qiu M; Huang S; Luo C; Wu Z; Liang B; Huang H; Ci Z; Zhang D; Han L; Lin J
    Biomed Pharmacother; 2021 Jul; 139():111561. PubMed ID: 33848775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.
    Hirsh J; Anand SS; Halperin JL; Fuster V;
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):E9-9. PubMed ID: 11451763
    [No Abstract]   [Full Text] [Related]  

  • 6. The use and limitations of unfractionated heparin.
    Krishnaswamy A; Lincoff AM; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):35-40. PubMed ID: 20215909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in acute anticoagulation therapy: what improvements over traditional heparin are on the horizon?
    Carter CJ
    Postgrad Med; 1996 Jun; 99(6):129-36. PubMed ID: 8668626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties.
    Lippi G; Henry BM; Favaloro EJ
    Semin Thromb Hemost; 2023 Feb; 49(1):73-75. PubMed ID: 35158389
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of thrombotic and cardiovascular disorders in the new millenium.
    Fareed J; Hoppensteadt DA; Bick RL
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban to achieve therapeutic anticoagulation in two patients with acute thrombosis and heparin resistance.
    Mindlina I; Nelmes E; Sharp M; Butler A; Gudgin E; Thomas W
    Blood Coagul Fibrinolysis; 2019 Dec; 30(8):426-428. PubMed ID: 31567267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Pharmacology of Unfractionated Heparin.
    Derbalah A; Duffull S; Newall F; Moynihan K; Al-Sallami H
    Clin Pharmacokinet; 2019 Aug; 58(8):1015-1028. PubMed ID: 30850987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.
    Hirsh J; Anand SS; Halperin JL; Fuster V;
    Circulation; 2001 Jun; 103(24):2994-3018. PubMed ID: 11413093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant therapy in cardiovascular diseases. II. Clinical problems of anticoagulant therapy].
    Latallo ZS; Malanowicz W
    Kardiol Pol; 1971; 14(1):99-107. PubMed ID: 5552716
    [No Abstract]   [Full Text] [Related]  

  • 14. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments.
    Kalathottukaren MT; Haynes CA; Kizhakkedathu JN
    Drug Deliv Transl Res; 2018 Aug; 8(4):928-944. PubMed ID: 28741113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants].
    Latallo ZS; Malanowicz W
    Kardiol Pol; 1970; 13(4):351-8. PubMed ID: 4099312
    [No Abstract]   [Full Text] [Related]  

  • 16. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
    Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
    [No Abstract]   [Full Text] [Related]  

  • 17. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.
    Sciascia S; Radin M; Schreiber K; Fenoglio R; Baldovino S; Roccatello D
    Intern Emerg Med; 2017 Dec; 12(8):1101-1108. PubMed ID: 28929298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining Approaches to Asthma: Bridging the Gap Between Heparin and Its Anti-inflammatory Activities.
    Shastri MD; Peterson GM; Patel RP
    Curr Allergy Asthma Rep; 2017 Oct; 17(10):70. PubMed ID: 28929391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.